Caricamento...
Chemotherapy with paclitaxel plus carboplatin for relapsed advanced thymic carcinoma
OBJECTIVE: For rarity of thymic carcinoma, no definitive chemotherapeutic regimen has been established in second- or further-line settings. The aim of this study was to evaluate the feasibility and safety of paclitaxel plus carboplatin in advanced thymic carcinoma as second- or further-line treatmen...
Salvato in:
| Pubblicato in: | J Thorac Dis |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Pioneer Bioscience Publishing Company
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283302/ https://ncbi.nlm.nih.gov/pubmed/25589977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2014.11.18 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|